Skip to content
Facebook Twitter Linkedin
InMed-logo-01
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Analogs
  • Manufacturing
    • BayMedica – Rare Cannabinoid Ingredients
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Analogs
  • Manufacturing
    • BayMedica – Rare Cannabinoid Ingredients
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn

Filings

Form TypeForm DescriptionFiling DateReport DateView Report
PRE 14AOther preliminary proxy statements2025-04-292025-04-29
8-KCurrent report2025-04-252025-04-25
8-KCurrent report2025-04-082025-04-04
SCHEDULE 13G/AForm - SCHEDULE 13G - amended2025-04-02
8-KCurrent report2025-02-142025-02-10
8-KCurrent report2025-02-132025-02-12
10-QQuarterly report [Sections 13 or 15(d)]2025-02-122024-12-31
4Statement of changes in beneficial ownership of securities2025-02-032025-01-11
8-KCurrent report2025-02-032025-02-03
8-KCurrent report2025-01-222025-01-22
8-KCurrent report2025-01-212025-01-21
SCHEDULE 13G/AForm - SCHEDULE 13G - amended2025-01-03
424B3Prospectus [Rule 424(b)(3)]2025-01-02
EFFECTNotice of Effectiveness2024-12-31
S-1/AGeneral form for registration of securities under the Securities Act of 1933 - amended2024-12-30
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
S-1General form for registration of securities under the Securities Act of 19332024-12-23
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
4Statement of changes in beneficial ownership of securities2024-12-232024-12-20
S-8Securities to be offered to employees in employee benefit plans2024-12-20
8-KCurrent report2024-12-192024-12-18
8-KCurrent report2024-12-182024-12-13
SCHEDULE 13GForm - SCHEDULE 13G2024-12-18
8-KCurrent report2024-11-202024-11-19
  • 1
  • 2
  • 3
  • …
  • 14
  • Next »

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More
InMed-logo-mono

#1455 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

  • INM-901 for Alzheimer’s Disease
  • INM-089 for Age-related Macular Degeneration
  • INM-755 for Epidermolysis Bullosa
  • INM-088 for Glaucoma
  • Novel Analogs

MANUFACTURING

  • BayMedica – Rare Cannabinoid Ingredients
  • Cannabinoid Manufacturing Expertise
  • IntegraSyn™ Cannabinoid Manufacturing

Investor

  • News
  • Events
  • Stock Information
  • Corporate Governance
  • Financials & AGM Materials
  • Filings
  • Presentations
  • Media & Videos
  • Investor Contact

CORPORATE

  • Management
  • Board of Directors
  • Scientific Advisors
  • Partners and Collaborators
  • Careers
  • Contact

Learn

  • What is Cannabinol (CBN)?
  • What is Epidermolysis Bullosa (EB)?
  • What is Glaucoma?
  • Cannabinoid Manufacturing Economics 101
  • GMP Manufacturing Standards by Product Type
  • Cannabinoids for Glaucoma
  • Cannabinoid Science
  • Articles and Videos

© Copyright 2025 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On:
Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*